Summary
Before the advent of ubiquitin immunocytochemistry and immunogold electron microscopy, there was no known intracellular molecular commonality between neurodegenerative diseases. The application of antibodies which primarily detect ubiquitin protein conjugates has shown that all of the human and animal idiopathic and transmissible chronic neurodegenerative diseases, (including Alzheimer’s disease (AD), Lewy body disease (LBD), amyotrophic lateral sclerosis (ALS), Creutzfeldt-Jakob disease (CJD) and scrapie) are related by some form of intraneuronal inclusion which contains ubiquitin protein conjugates.
In addition, disorders such as Alzheimer’s disease, CJD and sheep scrapie, are characterised by deposits of amyloid, arising through incomplete breakdown of membrane proteins which may be associated with cytoskeletal reorganisation. Although our knowledge about these diseases is increasing, they remain largely untreatable. Recently, attention has focussed on the mechanisms of production of different types of amyloid and the likely involvement within cells of the endosome-lysosome system, organelles which are immuno-positive for ubiquitin protein conjugates. These organelles may be ‘bioreactor’ sites for the unfolding and partial degradation of membrane proteins to generate the amyloid materials or their precursors which subsequently become expelled from the cell, or are released from dead cells, and accumulate as pathological entities. Such common features of the disease processes give new direction to therapeutic intervention.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arnold JE, Tipler C, Laszlo L, Hope J, Landon M, Mayer RJ. The abnormal form of the prion protein accumulates in endosome/lysosome-like organelles in scrapie-infected mouse brain. J. Pathol. 1995; In press.
Benowitz LI, Rodriguez W, Paskevich P, Mufson EJ, Schenk D, Neve RL. The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp. Neurol. 1989;106:237–250.
Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 1992;267:16188–16199.
Bueler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993;73:1339–1347.
Bueler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992;356:577–582.
Byrne EJ, Lennox GG, Godwin-Austen RB, et al. Dementia associated with cortical Lewy bodies: proposed clinical diagnostic criteria. Dementia 1991;2:283–284.
Cataldo AM, Paskevich PA, Kominami E, Nixon RA. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 1991;88:10998–11002.
Cenciarelli C, Hou D, Hsu KC, et al. Activation-induced ubiquitination of the T-cell antigen receptor. Science 1992;257:795–797.
Collinge J, Owen F, Poulter M, et al. Prion dementia without characteristic pathology. Lancet 1990;336:7–9.
Corder E H, Saunders AM, Strittmatter, W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late-onset families. Science 1993;261:921–923.
DeArmond SJ. Alzheimer’s disease and Creutzfeldt-Jakob disease: overlap of pathogenic mechanisms. Current Opinion in Neurology 1993;6:872–881.
Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen S-H. Ubiquitin immunoreactive structures in normal human brains. Lab. Invest. 1990;63:87–99.
Esch FS, Keim PS, Beattie EC, et al. Cleavage of amyloid b-peptide during constitutive processing of its precursor. Science 1990;248:1122–1124.
Gropper R, Brandt RA, Elias S, et al. The ubiquitin-activating enzyme, El, is required for stress-induced lysosomal degradation of cellular proteins. J. Biol. Chem. 1991;266:3602–3610.
Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface ß-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1992;357:500–503.
Jarrett JT, Berger EP, Lansbury PT. The carboxy terminus of the beta-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease. Biochemistry 1993;32:4693–4697.
Jensen T G, Roses A D and Jorgensen A L. Apolipoprotein E uptake and degradation via chloroquine-sensitive pathway in cultivated monkey cells overexpressing low density lipoprotein receptor. Neurosci. Lett. 1994;180:193–196.
Kwak S, Masaki T, Ishiura S. and Sugita H. Multicatalytic proteinase is present in Lewy bodies in neurofibrillary tangles in diffuse Lewy body disease brains. Neurosci. Lett. 1991;128:21–24.
Laszlo L, Lowe J, Self T, et al. Lysosomes are key organelles in the pathogensis of prion encephalopathies. J. Pathol. 1992;166:333–341.
Laszlo L, Tuckwell J, Self T, et al. The latent membrane protein-1 in Epstein-Barr virus-transformed lymphoblastoid cells is found with ubiquitin-protein conjugates and heat-shock protein-70 in lysosomes oriented around the microtubule organizing centre. J. Pathol. 1991;164:203–214.
Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J. Neurol. Neurosurg. Psychiatr. 1989a;52:1236–1247.
Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J. Neurol. Neurosurg. Psychiatr. 1989b;52:67–71.
Low P, Doherty FJ, Sass M, Kovacs J, Mayer RJ, Laszlo L. Immunogold localisation of ubiquitin-protein conjugates in Sf9 insect cells: implications for the biogenesis of lysosome-related organelles. FEBS Lett. 1993;316:152–156.
Lowe J, Mayer RJ, Landon M. Ubiquitin in neurodegenerative diseases. Brain Pathol. 1993;3:55–65.
Lowe J, Fergusson J, Kenward N, et al. Immunoreactivity to ubiquitin-protein conjugates is present early in the disease process in the brains of scrapie-infected mice. J. Pathol. 1992;168:169–177.
Lowe J, Mayer RJ. Ubiquitin, cell stress and diseases of the nervous system. Neuropathol. Appl. Neurobiol. 1990;16:281–291.
Ma J, Yee A, Brewer H.B Jnr, Das S and Potter H. Amyloid-associated proteins a1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer b- protein into filaments. Nature 1994;372:92–94.
Mayer RJ, Landon M, Laszlo L, Lennox G, Lowe J. Protein processing in lysosomes - the new therapeutic target in neurodegenerative disease. Lancet 1992;340:156–159.
Mayer RJ, Arnold J, Laszlo L, Landon M, Lowe J. Ubiquitin in health and disease. Biochim. Biophys. Acta 1991;1089:141–157.
McKinley MP, Taraboulos A, Kenaga L, et al. Ultrastructural localisation of scrapie prions in cytoplasmic vesicles of infected cultured cells. Lab. Invest. 1991;65:622–630.
Namba Y, Tomonaga M, Kawasaki H, Otomo E and Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and Kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541:163–166.
Prusiner SB. Chemistry and biology of prions. Biochemistry 1992;31:12277–12288.
Prusiner SB. Molecular biology of prion diseases. Science 1991;252:1515–1522.
Seubert P, Oltersdorf T, Lee MG, et al. Secretion of b-amyloid precursor protein cleaved at the amino terminus of the b-amyloid peptide. Nature 1993;361:260–263.
Shyng S -L, Heuser J E and Harris D A. A glycolipid-anchored prion protein is endocytosed via clathrin coated pits. J. Cell Biol. 1994;125:1239–1250.
Siman R, Mistretta S, Durkin JT, et al. Processing of the b-amyloid precursor. J. Biol. Chem. 1993;268:16602–16609.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Mayer, R.J. et al. (1996). Endosome-Lysosomes, Ubiquitin and Neurodegeneration. In: Suzuki, K., Bond, J.S. (eds) Intracellular Protein Catabolism. Advances in Experimental Medicine and Biology, vol 389. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0335-0_33
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0335-0_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8003-0
Online ISBN: 978-1-4613-0335-0
eBook Packages: Springer Book Archive